The British In Vitro Diagnostic Association (BIVDA) has submitted a response to the government’s new Innovation Taskforce, set up by the Prime Minister.
The SHOT team will host a webinar on 12 March, 1300–1400 GMT, covering the HTR chapter of the Annual SHOT Report 2019, with a look at hyperhaemolysis cases and patients with haemoglobinopathies. Click on this story for the link to register.
Torrey Pines Scientific has announced its new EchoTherm HPLC Column Oven Model CO20. The temperature range is from room temperature to 90.0°C readable and settable to 0.1°C.
Tecan has launched the Frida Reader for the Fluent Automation Workstation, offering researchers the ability to quantify nucleic acids without sample loss.
New research, published recently in the Journal of Medical Microbiology, has found that fidaxomicin is more effective than existing tuberculosis (TB) medication at preventing growth of Mycobacterium tuberculosis.
Scientific Laboratory Supplies (SLS) has announced further consolidation of its relationship with Merck through its appointment as an official distributor for the Supelco range of analytical products.
Cell Guidance Systems, a specialist in the control, manipulation and monitoring of cells has announced its POlyhedrin Delivery System (PODS) technology has been shown to modulate macrophage secretion profiles with therapeutic potential.
HORIBA Medical has obtained CE-mark certification for the Microsemi CRP LC-767G, its new generation of the Microsemi CRP haematology analyser.
Olympus is launching NoviSight 3D analysis software globally. For life science research that relies on cell analysis, the information provided by NoviSight software can improve the entire experimental process.
HORIBA UK, Medical has announced that HORIBA and HORIBA Instruments have acquired MedTest Holdings, comprising MedTest Dx, Pointe Scientific, Clinitox Diagnostix and Medical Laboratory Solutions.
Tecan is one of the first companies to meet the requirements of the European Union’s In Vitro Diagnostic Regulation (IVD-R) 2017/746 (Annex IX, Chapter I and III).